PCM Encore’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
PCM Encore's CRL Position: Q3 2026 in Review
PCM Encore opened a new position in Charles River Laboratories (CRL) in Q3 2026: 768 shares worth $227K. The stake represents 0.04% of the portfolio and ranks #399 among its holdings.
646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- PCM Encore held 768 shares of Charles River Laboratories worth $227K as of Q3 2026.
- Charles River Laboratories was a new PCM Encore position in Q3 2026.
- Charles River Laboratories made up 0.04% of PCM Encore's portfolio in Q3 2026, its #399 holding.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on PCM Encore's 13F filing for Q3 2026, filed 19 Nov 2026.